Rifampicin is predicted to decrease
cinacalcet levels by inducing its
metabolism by CYP3A4. This seems a reasonable prediction as potent CYP3A4 inhibitors raise
cinacalcet levels.
It may be prudent to monitor parathyroid hormone and
serum calcium more frequently if
rifampicin is started or stopped.